Special Survey for Type 1 or Type 2 Diabetic Patients

Novo Nordisk

Status: Completed

Conditions: Diabetes Mellitus, Type 1; Diabetes; Diabetes Mellitus, Type 2

Treatments: Drug: insulin aspart

Study type: Observational

Funder types: Industry

Identifiers

NCT01487408

ANA-1944

Details and patient eligibility

About

This study is conducted in Japan. The aim of this study is to evaluate the incidence of severe hypoglycaemia episodes under normal clinical practice for patients with type 1 or type 2 diabetes.

Enrollment: 1,463 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with diabetes requiring insulin therapy

Exclusion criteria

• Patients who had not been treated more than 3 months at the same investigational site
• Patients who had treatment history of NovoRapid® (insulin aspart)

Trial design

1,463 participants in 1 patient group

Insulin Aspart

Treatment:

Drug: insulin aspart